Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti-PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial.
Timothée OlivierVinay PrasadPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)